Update shared on 10 Nov 2025
Narrative Update: Attendo Analyst Price Target Change
Analysts have maintained their fair value estimate for Attendo at SEK 83.50, noting negligible adjustments to underlying forecasts and valuation inputs in their latest update.
What's in the News
- Completed the repurchase of 1,563,391 shares, representing 1.05% of the company, for SEK 106.24 million in connection with the buyback announced on July 29, 2025 (Key Developments).
- Terminated two smaller agreements in Katrineholm and Nykoping, Sweden, affecting approximately 60 employees and 180 customers, due to lack of sustainable conditions. The agreements have no material impact on results (Key Developments).
- Continues to focus on delivering better care at a lower cost in partnership with municipalities as the basis of its strategy (Key Developments).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at SEK 83.50.
- Discount Rate decreased slightly from 6.07% to 6.06%.
- Revenue Growth estimate remains stable at approximately 2.87%.
- Net Profit Margin is unchanged and holds at 4.39%.
- Future P/E Ratio is virtually flat, moving minimally from 13.87x to 13.87x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.